These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Elson CJ, Scott DG, Blake DR, Bacon PA, Holt PD. Ann Rheum Dis; 1983 Apr; 42(2):147-50. PubMed ID: 6601932 [Abstract] [Full Text] [Related]
25. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Ann Rheum Dis; 1996 Mar; 55(3):190-2. PubMed ID: 8712883 [Abstract] [Full Text] [Related]
26. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Geirsson AJ, Sturfelt G, Truedsson L. Ann Rheum Dis; 1987 Oct; 46(10):727-33. PubMed ID: 3689000 [Abstract] [Full Text] [Related]
31. HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study. Lagha A, Messadi A, Boussaidi S, Kochbati S, Tazeghdenti A, Ghazouani E, Almawi WY, Yacoubi-Loueslati B. HLA; 2016 Sep; 88(3):100-9. PubMed ID: 27580864 [Abstract] [Full Text] [Related]
32. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z. Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568 [Abstract] [Full Text] [Related]
33. [Extra-articular manifestations of rheumatoid polyarthritis]. De Bandt M, Meyer O. Rev Prat; 1997 Nov 15; 47(18):2012-6. PubMed ID: 9501618 [Abstract] [Full Text] [Related]
36. HLA class II alleles influence rheumatoid arthritis susceptibility and autoantibody status in South Indian Tamil population. Mariaselvam CM, Fortier C, Charron D, Krishnamoorthy R, Tamouza R, Negi VS. HLA; 2016 Nov 15; 88(5):253-258. PubMed ID: 27753285 [Abstract] [Full Text] [Related]
37. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. Clin Exp Immunol; 1981 Jan 15; 43(1):54-63. PubMed ID: 7249394 [Abstract] [Full Text] [Related]
38. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Combe B, Didry C, Gutierrez M, Anaya JM, Sany J. Eur J Med; 1993 Mar 15; 2(3):153-6. PubMed ID: 8261056 [Abstract] [Full Text] [Related]
39. [Clinico-immunological characteristics of patients with rheumatoid arthritis and symptoms of cutaneous vasculitis (cooperative Soviet-Polish study)]. Nasonova VA, Alekberova ZS, Balabanova RM, Sadowska-Wrublewska M, Filipowicz-Sosnowska A, Garwolińska G, Weryńska-Przybylska Z. Klin Med (Mosk); 1990 Jun 15; 68(6):33-7. PubMed ID: 2145468 [Abstract] [Full Text] [Related]
40. Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes. Venables PJ, Erhardt CC, Maini RN. Clin Exp Immunol; 1980 Jan 15; 39(1):146-53. PubMed ID: 6771070 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]